#ECCMID2023 SABATO Trial - early oral switch in SAB: non-inferiority of PO switch after 5–7 days of IV vs. 14-day IV in patients at low risk of complications (presented last year at ECCMID2022-final paper not published yet?) https://t.co/8xCU0imIH5
RT @edenhelmi: @ABsteward I think SOBATO did that: Echo was mandatory only in those with ESRD TRO IE and patients with a pacemaker/automati…
@ABsteward I think SOBATO did that: Echo was mandatory only in those with ESRD TRO IE and patients with a pacemaker/automatic implantable cardioverter-defibrillator TRO device-associated infection https://t.co/8WLNMdNkJL
@jd_wilko Sabato trial screened >5,000 to recruit ~200. Sure trial is underpowered but totally useful information (results still being written up) https://t.co/ptxDKQTjAw